Virginia-Maryland College of Veterinary Medicine
Results for: Immunology
Article ItemAbdelhamid awarded 'Nutrients" Travel Award in Nutritional Immunology , article
Department of Biomedical Sciences and Pathobiology Ph.D. student Leila Abdelhamid received the Nutrients Travel Award in Nutritional Immunology for 2021. Abdelhamid's research in the Luo Lab explores the complex cellular and molecular pathways of how vitamin A modulates the inflammation-associated with systemic autoimmunity.
Article ItemPrincipal investigator Caswell awarded NIH R21 grant , article
A new, two-year NIH R21 grant has been awarded to principal investigator Clay Caswell to investigate the role and impact of small regulatory RNAs on the virulence of Brucella spp.
Article ItemEdwards, Cecere, and Ahmed publish in Scientific Reports , article
Edwards, MR, Dai, R., Heid, B., Cowan, C, Were, SR, Cecere, T., Ansar Ahmed, S. published "Low-dose 17α-ethinyl estradiol (EE) exposure exacerbates lupus renal disease and modulates immune responses to TLR7/9 agonists in genetically autoimmune-prone mice" in Scientific Reports 2020.
Article ItemPrincipal investigators Meng and Ahmed awarded NIH T32 grant , article
A new, five-year NIH T32 grant awarded to principal investigators X.J. Meng and Ansar Ahmed will enable VA-MD Vet Med researchers and faculty mentors university-wide to train veterinarians to become world-class biomedical researchers who pursue a research-related careers
Article ItemSwartwout awarded NIH F31 predoctoral grant , article
An NIH F31 predoctoral grant has been awarded to Translational Biology, Medicine, and Health doctoral student Brianna Swartwout, who works in the lab of Xin Luo, associate professor of immunology in the Department of Biomedical Sciences and Pathobiology.
Article ItemYuan awarded CureVac contract research project , article
Principal investigator Lijuan Yuan, professor of virology and immunology in the Department of Biomedical Sciences and Pathobiology, has secured a new $339,250 contract research project from CureVac, which will allow the development of a next-generation mRNA-based vaccine to combat rotavirus infections.